Cargando…

Silencing of insulin-like growth factor-1 receptor enhances the radiation sensitivity of human esophageal squamous cell carcinoma in vitro and in vivo

BACKGROUND: Esophageal squamous cell carcinoma (ESCC) is a prevalent fatal cancer worldwide, and the number of deaths due to this disease is increasing. Due to ESCC resistance to chemotherapy and radiation treatment, new therapies are urgently needed for the improvement of ESCC patient clinical outc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Hui, Gu, Xiaomeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232704/ https://www.ncbi.nlm.nih.gov/pubmed/25363593 http://dx.doi.org/10.1186/1477-7819-12-325

Ejemplares similares

Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR In Vitro and In Vivo
por: Shi, Xiaodan, et al.
Publicado: (2021)

Raltitrexed increases radiation sensitivity of esophageal squamous carcinoma cells
por: Ding, Wen-Xiu, et al.
Publicado: (2019)

Insulin-Like Growth Factor 2 Silencing Restores Taxol Sensitivity in Drug Resistant Ovarian Cancer
por: Brouwer-Visser, Jurriaan, et al.
Publicado: (2014)

Targeted therapy of the AKT kinase inhibits esophageal squamous cell carcinoma growth in vitro and in vivo
por: Liu, Xuejiao, et al.
Publicado: (2019)

Xanthohumol Inhibits the Growth of Keratin 18-Overexpressed Esophageal Squamous Cell Carcinoma in vitro and in vivo
por: Yin, Shuying, et al.
Publicado: (2020)

Nuplazid suppresses esophageal squamous cell carcinoma growth in vitro and in vivo by targeting PAK4
por: Wei, Yaxing, et al.
Publicado: (2021)

Non-thermal plasma inhibits tumor growth and proliferation and enhances the sensitivity to radiation in vitro and in vivo
por: Lin, Lin, et al.
Publicado: (2018)

Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study
por: Cui, Yuzhong, et al.
Publicado: (2022)

Cirsiliol targets tyrosine kinase 2 to inhibit esophageal squamous cell carcinoma growth in vitro and in vivo
por: Jia, Xuechao, et al.
Publicado: (2021)

Dasabuvir suppresses esophageal squamous cell carcinoma growth in vitro and in vivo through targeting ROCK1
por: Liu, Xinning, et al.
Publicado: (2023)

Silencing of the type 1 insulin-like growth factor receptor increases the sensitivity to apoptosis and inhibits invasion in human lung adenocarcinoma A549 cells
por: Ma, Zhiyuan, et al.
Publicado: (2007)

Effects of RNA silencing of matrix metalloproteinase-2 on the growth of esophageal carcinoma cells in vivo
por: Shen, Yu-Guang, et al.
Publicado: (2017)

Telomerase antagonist imetelstat increases radiation sensitivity in esophageal squamous cell carcinoma
por: Wu, Xuping, et al.
Publicado: (2017)

Upregulation of miR-194-5p or silencing of PRC1 enhances radiotherapy sensitivity in esophageal squamous carcinoma cells
por: Wang, Yan, et al.
Publicado: (2023)

Insulin-like growth factor binding protein-3 is a new predictor of radiosensitivity on esophageal squamous cell carcinoma
por: Luo, Li-Ling, et al.
Publicado: (2015)

Association of insulin-like growth factor-binding protein-3 with radiotherapy response and prognosis of esophageal squamous cell carcinoma
por: Luo, Li-Ling, et al.
Publicado: (2015)

Correction to: Therapeutic benefits of niraparib tosylate as radio sensitizer in esophageal squamous cell carcinoma: an in vivo and in vitro preclinical study
por: Cui, Yuzhong, et al.
Publicado: (2022)

MicroRNA-338-3p suppresses tumor growth of esophageal squamous cell carcinoma in vitro and in vivo
por: Li, Xinyu, et al.
Publicado: (2021)

Inhibition of human esophageal squamous cell carcinomas by targeted silencing of tumor enhancer genes: an overview
por: Islamian, Jalil Pirayesh, et al.
Publicado: (2014)

Toll-like receptor 9 expression is associated with breast cancer sensitivity to the growth inhibitory effects of bisphosphonates in vitro and in vivo
por: Sandholm, Jouko, et al.
Publicado: (2016)

Methylation silencing of TGF-β receptor type II is involved in malignant transformation of esophageal squamous cell carcinoma
por: Ma, Yarui, et al.
Publicado: (2020)

Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo
por: Matsui, Takanori, et al.
Publicado: (2019)

Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells
por: Chen, Chuangui, et al.
Publicado: (2017)

Role of Insulin-like Growth Factor, Insulin-like Growth Factor Receptors, and Insulin-like Growth Factor-binding Proteins in Ovarian Cancer
por: Amutha, Periyasamy, et al.
Publicado: (2017)

NRP-1 silencing suppresses hepatocellular carcinoma cell growth in vitro and in vivo
por: XU, JING, et al.
Publicado: (2013)

In vitro silencing of the insulin receptor attenuates cellular accumulation of fibronectin in renal mesangial cells
por: Yano, Naohiro, et al.
Publicado: (2012)

How insulin-like growth factor I binds to a hybrid insulin receptor type 1 insulin-like growth factor receptor
por: Xu, Yibin, et al.
Publicado: (2022)

Ets2 knockdown inhibits tumorigenesis in esophageal squamous cell carcinoma in vivo and in vitro
por: Li, Qinghua, et al.
Publicado: (2016)

The Insulin-Like Growth Factor-1 Receptor Is a Negative Regulator of Nitric Oxide Bioavailability and Insulin Sensitivity in the Endothelium
por: Abbas, Afroze, et al.
Publicado: (2011)

(S)-10-Hydroxycamptothecin Inhibits Esophageal Squamous Cell Carcinoma Growth In Vitro and In Vivo Via Decreasing Topoisomerase I Enzyme Activity
por: Song, Mengqiu, et al.
Publicado: (2019)

Co-inhibition of BMI1 and Mel18 enhances chemosensitivity of esophageal squamous cell carcinoma in vitro and in vivo
por: Wang, Jiansong, et al.
Publicado: (2019)

Metformin inhibited esophageal squamous cell carcinoma proliferation in vitro and in vivo and enhanced the anti-cancer effect of cisplatin
por: Wang, Feng, et al.
Publicado: (2017)

GSK1838705A, an insulin-like growth factor-1 receptor/insulin receptor inhibitor, induces apoptosis and reduces viability of docetaxel-resistant prostate cancer cells both in vitro and in vivo
por: Zhou, Fayou, et al.
Publicado: (2015)

CMHX008, a Novel Peroxisome Proliferator-Activated Receptor γ Partial Agonist, Enhances Insulin Sensitivity In Vitro and In Vivo
por: Ming, Yue, et al.
Publicado: (2014)

Quantitative analysis of insulin-like growth factor 2 receptor and insulin-like growth factor binding proteins to identify control mechanisms for insulin-like growth factor 1 receptor phosphorylation
por: Tian, Dan, et al.
Publicado: (2016)

Heterodimerization of Glycosylated Insulin-Like Growth Factor-1 Receptors and Insulin Receptors in Cancer Cells Sensitive to Anti-IGF1R Antibody
por: Kim, Jun Gyu, et al.
Publicado: (2012)

Correlation between insulin-like growth factor binding protein 3 and metastasis-associated gene 1 protein in esophageal squamous cell carcinoma
por: YANG, HAIPING, et al.
Publicado: (2016)

Epigenetic silencing of ZNF132 mediated by methylation-sensitive Sp1 binding promotes cancer progression in esophageal squamous cell carcinoma
por: Jiang, Dong, et al.
Publicado: (2018)

Epigenetic silencing of TMEM176A promotes esophageal squamous cell cancer development
por: Wang, Ying, et al.
Publicado: (2017)

Deciphering Brain Insulin Receptor and Insulin‐Like Growth Factor 1 Receptor Signalling
por: Kleinridders, A.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_59ofdif7en02b3is0078k0t04m